C. Egsmose

710 total citations
21 papers, 581 citations indexed

About

C. Egsmose is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Nephrology. According to data from OpenAlex, C. Egsmose has authored 21 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 5 papers in Orthopedics and Sports Medicine and 4 papers in Nephrology. Recurrent topics in C. Egsmose's work include Rheumatoid Arthritis Research and Therapies (8 papers), Parathyroid Disorders and Treatments (4 papers) and Inflammatory mediators and NSAID effects (3 papers). C. Egsmose is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Parathyroid Disorders and Treatments (4 papers) and Inflammatory mediators and NSAID effects (3 papers). C. Egsmose collaborates with scholars based in Denmark. C. Egsmose's co-authors include B. Lund, L Trang, G Borg, Einar Berg, Ulf Brodin, H. Pettersson, Ole Rintek Madsen, Henning Bliddal, Jesper Sylvest and Troels Mørk Hansen and has published in prestigious journals such as Cellular and Molecular Life Sciences, Annals of the Rheumatic Diseases and Journal of Internal Medicine.

In The Last Decade

C. Egsmose

21 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Egsmose Denmark 11 438 144 76 71 56 21 581
M. A. Cimmino Italy 10 280 0.6× 58 0.4× 83 1.1× 35 0.5× 39 0.7× 29 445
Y Pawlotsky France 11 137 0.3× 161 1.1× 64 0.8× 48 0.7× 116 2.1× 52 480
Lesley Hordon United Kingdom 13 295 0.7× 105 0.7× 117 1.5× 98 1.4× 47 0.8× 26 676
Zuzana Tatar France 15 334 0.8× 60 0.4× 145 1.9× 44 0.6× 64 1.1× 29 596
Robin Munro United Kingdom 12 551 1.3× 202 1.4× 69 0.9× 73 1.0× 110 2.0× 16 740
Abdurhman S Al-Arfaj Saudi Arabia 12 328 0.7× 54 0.4× 107 1.4× 69 1.0× 17 0.3× 40 524
A Steuer United Kingdom 10 336 0.8× 107 0.7× 113 1.5× 35 0.5× 34 0.6× 26 528
M. Manara Italy 16 370 0.8× 111 0.8× 134 1.8× 81 1.1× 28 0.5× 46 690
P. Dantis Greece 8 369 0.8× 32 0.2× 109 1.4× 117 1.6× 14 0.3× 11 637
Ernest Suresh Singapore 12 206 0.5× 42 0.3× 78 1.0× 59 0.8× 32 0.6× 35 532

Countries citing papers authored by C. Egsmose

Since Specialization
Citations

This map shows the geographic impact of C. Egsmose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Egsmose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Egsmose more than expected).

Fields of papers citing papers by C. Egsmose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Egsmose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Egsmose. The network helps show where C. Egsmose may publish in the future.

Co-authorship network of co-authors of C. Egsmose

This figure shows the co-authorship network connecting the top 25 collaborators of C. Egsmose. A scholar is included among the top collaborators of C. Egsmose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Egsmose. C. Egsmose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huynh, Tuan Khai, et al.. (2013). FRI0177 Patient and health professional preferences to route of administration of biologic agents for ra treatment. Annals of the Rheumatic Diseases. 72. A431–A432. 1 indexed citations
2.
3.
Madsen, Ole Rintek, et al.. (2004). Bone status in rheumatoid arthritis assessed at peripheral sites by three different quantitative ultrasound devices. Clinical Rheumatology. 23(4). 324–329. 7 indexed citations
4.
Madsen, Ole Rintek & C. Egsmose. (2001). Associations of Isokinetic Knee Extensor and Flexor Strength with Steroid Use and Walking Ability in Women with Rheumatoid Arthritis. Clinical Rheumatology. 20(3). 207–212. 12 indexed citations
5.
Madsen, Ole Rintek, et al.. (1998). Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis.. PubMed. 16(1). 27–32. 28 indexed citations
6.
Egsmose, C., et al.. (1997). Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Annals of the Rheumatic Diseases. 56(1). 32–36. 40 indexed citations
7.
8.
Brandi, Lisbet, Henrik Daugaard, C. Egsmose, et al.. (1996). Intermittent intravenous followed by intermittent oral 1α(OH)D3 treatment of secondary hyperparathyroidism in uraemia. Journal of Internal Medicine. 239(4). 353–360. 6 indexed citations
9.
Madsen, Ole Rintek, Henning Bliddal, C. Egsmose, & Jesper Sylvest. (1995). Isometric and isokinetic quadriceps strength in gonarthrosis; Inter-relations between quadriceps strength, walking ability, radiology, subchondral bone density and pain. Clinical Rheumatology. 14(3). 308–314. 63 indexed citations
10.
Kamby, Claus, C. Egsmose, György Sölétormos, & P Dombernowsky. (1993). The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancer. Scandinavian Journal of Clinical and Laboratory Investigation. 53(5). 439–446. 7 indexed citations
11.
Egsmose, C., et al.. (1993). Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.. Annals of the Rheumatic Diseases. 52(10). 711–715. 51 indexed citations
12.
Jacobsen, Søren, et al.. (1993). Bone mass and turnover in fibromyalgia.. PubMed. 20(5). 856–9. 13 indexed citations
13.
Brandi, Lisbet, Henrik Daugaard, Erling Tvedegaard, et al.. (1992). Long-Term Suppression of Secondary Hyperparathyroidism by Intravenous 1&alpha;-Hydroxy vitamin D<sub>3</sub> in Patients on Chronic Hemodialysis. American Journal of Nephrology. 12(5). 311–318. 14 indexed citations
14.
Egsmose, C., B. Lund, & R. Bach Andersen. (1988). Timegadine: More Than a Non-steroidal for the Treatment of Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 17(2). 103–111. 5 indexed citations
15.
Gotzsche, P. C, F. Andreasen, C. Egsmose, & B. Lund. (1988). Steady State Pharmacokinetics of Naproxen in Elderly Rheumatics Compared with Young Volunteers. Scandinavian Journal of Rheumatology. 17(1). 11–16. 9 indexed citations
16.
Lund, B., C. Egsmose, Finn Stener Jørgensen, & Michael R. Krogsgaard. (1987). Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica. Calcified Tissue International. 41(6). 316–320. 16 indexed citations
17.
Lund, B., et al.. (1986). Pharmacokinetic profile of indoprofen in elderly subjects.. British Journal of Clinical Pharmacology. 22(6). 721–724. 1 indexed citations
18.
Egsmose, C., Elisabeth Bock, Kjeld Møllgård, & Niels A. Thorn. (1985). Immunocytochemical demonstration of calmodulin in cells secreting by exocytosis. Cellular and Molecular Life Sciences. 41(10). 1340–1342. 3 indexed citations
19.
Lund, B., P. Charles, C. Egsmose, et al.. (1985). Changes in vitamin D metabolites and bone histology in rats during recovery from rickets. Calcified Tissue International. 37(5). 478–83. 10 indexed citations
20.
Egsmose, C., et al.. (1984). In vitro evidence of the calcium-sparing effect of deflazacort.. PubMed. 171. 149–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. A. Cimmino Breakdown of academic impact, for papers by Y Pawlotsky Breakdown of academic impact, for papers by Lesley Hordon Breakdown of academic impact, for papers by Zuzana Tatar Breakdown of academic impact, for papers by Robin Munro Breakdown of academic impact, for papers by Abdurhman S Al-Arfaj Breakdown of academic impact, for papers by A Steuer Breakdown of academic impact, for papers by M. Manara Breakdown of academic impact, for papers by P. Dantis Breakdown of academic impact, for papers by Ernest Suresh
Rankless by CCL
2026